Humana Inc. Common Stock (HUM)
Stock · NYSE · Health Care
$385.54as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About HUM
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Med…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 67,060
- Website
- www.humana.com/
Fundamentals
- 1-day range
- $386.61$397
- Market cap
- $44.97B
- P/E (trailing)
- 36.09
- P/E (forward)
- 23.70
- EPS (trailing)
- $10.56
- Dividend yield
- 0.68%
- Beta
- 0.76
- Avg. volume
- 1.40M
- Ex-dividend date
- June 26, 2026
- Dividend pay date
- July 31, 2026
How Humana Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 19, 2026 · via SEC EDGAR / Finnhub
Forecasts
23 analyst ratings
Humana Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HUMHumana Inc. Common Stock$385.54▼ 1.81%Market cap $44.97BP/E 36.09$163.11$428.88
- NTRANatera Inc. Common Stock$326.47▼ 3.61%Market cap $38.72BP/E —$157.43$343.18
- CNCCentene Corporation Common Stock$64.77▼ 0.86%Market cap $31.50BP/E —$28.24$69.36
- ILMNIllumina Inc. Common Stock$215.65▼ 5.29%Market cap $29.98BP/E 34.73$88$231.81
- GHGuardant Health Inc. Common Stock$161.76▼ 4.01%Market cap $21.31BP/E —$53.4$176.58
- CIThe Cigna Group Common Stock$278.88▲ 0.44%Market cap $74.53BP/E 11.52$239.51$315.47
- MOHMolina Healthcare Inc Common Stock$199.88▲ 0.57%Market cap $10.17BP/E 1249.59$121.06$244.89
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HUM Humana Inc. Common Stock | $44.97B | 36.09 | $385.54 | ▼ 1.81% | $163.11$428.88 |
| NTRA Natera Inc. Common Stock | $38.72B | — | $326.47 | ▼ 3.61% | $157.43$343.18 |
| CNC Centene Corporation Common Stock | $31.50B | — | $64.77 | ▼ 0.86% | $28.24$69.36 |
| ILMN Illumina Inc. Common Stock | $29.98B | 34.73 | $215.65 | ▼ 5.29% | $88$231.81 |
| GH Guardant Health Inc. Common Stock | $21.31B | — | $161.76 | ▼ 4.01% | $53.4$176.58 |
| CI The Cigna Group Common Stock | $74.53B | 11.52 | $278.88 | ▲ 0.44% | $239.51$315.47 |
| MOH Molina Healthcare Inc Common Stock | $10.17B | 1249.59 | $199.88 | ▲ 0.57% | $121.06$244.89 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFsBenzinga · 8/14/2026
- The Signs Before UnitedHealth Stock Ran Were In Its Own Exit PlanYahoo · 8/13/2026
- CVS Health Stock's Next Leg Sits In Aetna's Unfinished Margin RepairYahoo · 8/13/2026
- Can Humana Improve Caregiver Retention With HealthStream Deal?Yahoo · 8/13/2026
- CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial LaunchesYahoo · 8/13/2026
- Diamond Hill Large Cap Fund Q2 2026 Portfolio UpdateSeekingAlpha · 8/13/2026
- Health insurers are dumping Medicare Advantage plans. Here’s how many seniors could be affected.Yahoo · 8/11/2026
- Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care WorkforceYahoo · 8/11/2026
Insider Activity
Insider Actions →- Paul John Smith · August 1, 2026 · Grant544
- Frederick John Crawford · August 1, 2026 · Grant544
- Kurt J. Hilzinger · June 30, 2026 · Grant233 @ $392.32
- Robert Stuart Field · May 1, 2026 · Grant852
- Aaron Martin · May 1, 2026 · Grant8.2K
- Japan Mehta · May 1, 2026 · Grant9.4K
- David Dintenfass · May 1, 2026 · Grant11.3K
- James A. Rechtin · May 1, 2026 · Grant35.6K
- Sanjay K. Shetty · May 1, 2026 · Grant9.9K
- Michelle A. O'Hara · May 1, 2026 · Grant10.5K
- Joseph C. Ventura · May 1, 2026 · Grant10.3K
- Mellet Celeste · May 1, 2026 · Grant15.4K
- Sanjay K. Shetty · April 1, 2026 · Tax Withholding401 @ $175.44
- Sanjay K. Shetty · April 1, 2026 · Option Exercise887
- George Renaudin II · March 31, 2026 · J25 @ $173.39
Institutional Ownership
March 31, 2026
- Total shares held
- 112.71M
- Total value held
- $19.22B
- Institutional holders
- 774
- Unknown11.38M
- Unknown10.20M
- Unknown7.84M
- Unknown5.47M
- Unknown5.45M
- Unknown4.48M
- Unknown3.73M
- Unknown3.33M
- Unknown2.97M
- Unknown2.86M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 29, 2026
Humana partners with DaVita on kidney care for MA members. Humana has entered a value-based care agreement with DaVita to coordinate care for its Medicare Advantage members with advanced chronic kidney disease (stages 3B-5). The arrangement aims to manage treatment for patients before they reach end-stage renal disease, a costly and complex condition for health plans. Separately, Humana was mentioned in Diamond Hill's Q2 2026 Small-Mid Cap portfolio review, indicating continued institutional interest in the stock. The partnership is relevant for Humana given its large Medicare Advantage membership and the high costs associated with late-stage kidney care.